New Delhi, Rajya Sabha chairman M Venkaiah Naidu on Monday said ultraviolet C-band radiation equipment has been installed in chambers of the House to contain the spread of coronavirus. See more
The first indigenous drug to treat COVID-19 is likely to be made available to the public soon with the completion of clinical trials, which showed “excellent results”, informed Tata Institute for Genetics and Society (TIGS) director Rakesh Mishra on Friday. See more
The Government's premier research body, CSIR may soon approach the Election Commission of India (ECI) to use its UV-C technology for mitigation of airborne transmission of SARS-COV-2 during indoor meetings with limited capacity for the ensuing Assembly polls in five poll bound States in the wake of ban on physical ralli... See more
As many as four coronavirus vaccine candidates are at different stages of human trials while one, developed by Genique Life Sciences, is in the advanced pre-clinical stage, Jitendra Singh, Union Science and Technology Minister, said in the Rajya Sabha on Tuesday. See more
CHANDIGARH: Punjab Chief Minister Captain Amarinder Singh on Tuesday virtually inaugurated a 100-bed makeshift Covid hospital at Talwandi Sabo in district Bathinda, scaling up the state’s preparedness for a third wave of the pandemic. See more
The Centre for Scientific and Industrial Research (CSIR) and Tata MD, the new healthcare venture from the Tata Group, have announced a significant partnership to ramp up the COVID-19 testing capacity across Tier II and III towns as well as rural areas across India. CSIR and Tata MD are developing this capacity to manage any future ... See more
CSIR is uniquely placed as an S&T organization to deliver these at this critical juncture, having proven expertise in sequencing (first human genome sequencing), diagnostics for rare genetic diseases and being the fountain head of generic industry in the country.
CSIR has advantageously positioned itself to pursue the focused R&D to develop, integrate, scale-up, and deploy necessary technological interventions for combating Coronavirus pandemic in the country. Considering the multifarious problems created by coronavirus which require interventions in several areas and multi-pronged strategy, CSIR has set up five technology verticals for addressing the emerging situation due to pandemic.
These verticals are need based and span multiple research labs and disciplines and draw upon the strength of scientists, students and harness it for the fight against COVID-19. In addition, CSIR is also working on promoting rural employment and providing ready to eat food to migrants and other outreach programs.
Including digital methods: to understand the genetic basis and develop strategy to combat COVID-19
Rapid and economical Diagnostics: Kits based on DNA and serological basis to diagnose the virus at an early stage
Development of new therapies, including repurposing of drugs and new drugs: Vaccine development
Cheap Hospital assistive devices and Personal Protective Equipment (PPE)
Supply chain management and logistics with regard to availability of materials and resources.
CSIR being aware that the task is formidable and cannot be accomplished alone, is working in close synergy with other government departments, ministries and agencies on one hand and on the other is hand with Industry, MSMEs and others for scale up, delivery and implementation.
CSIR is working with various industries to develop technologies and products to fight against COVID-19. View all the Technologies & Products
A dynamic forum for exchanging views, opinions, experiences, and popular insights into developments, technologies & techniques related to COVID-19. Goto CSIR Covid19 Blog
CSIR calls for R&D Proposals from Industry and Start Ups under NMITLI Scheme for breakthrough technological interventions against COVID-19
List of projects selected against CSIR-NMITLI Call for Proposals for tackling COVID-19 Click here
CSIR's Societal Programs for mitigating Coronavirus Pandemic
Promoting Rural Entrepreneurship and Employment - with support from industry
distributed and transferred technology of making reusable face masks
produced and distributed hand sanitizers and disinfectants
Recent videos showcasing CSIR's work on COVID-19
A Short Video of CSIR Fights COVID-19
An Overview of Rational Drug Design by Dr. Shekhar Mande, DG CSIR and Secretary, DSIR
Biopolymer Coated Facemasks developed using CSIR-NCL's patented bacterial nano cellulose technology
Nasopharyngeal Swab developed by CSIR-National Chemical Laboratory, Pune
Oxygen Enrichment Unit, a medical device developed by CSIR-NCL, Pune
Webinar: Testing, Prevention & Makeshift Hospitals: CSIR's COVID-19 Footprints (in Tamil)
CSIR has its presence across India in the form of 38 laboratories working in difference technologies and sector. More details can be sought on CSIR website
Council of Scientific & Industrial Research,
Anusandhan Bhawan
2, Rafi Ahmed Kidwai Marg,
New Delhi 110 001
rpsingh[at]csir[dot]res[dot]in
